Pfizer Inc. (0Q1N.IL)
| Previous close | 27.45 |
| Open | 27.88 |
| Bid | 26.60 x N/A |
| Ask | 29.30 x N/A |
| Day's range | 27.71 - 28.11 |
| 52-week range | 25.21 - 37.80 |
| Volume | |
| Avg. volume | 101,987 |
| Market cap | 169.7B |
| Beta (5Y monthly) | 0.57 |
| PE ratio (TTM) | 7.45 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.64 (5.31%) |
| Ex-dividend date | 08 Nov 2023 |
| 1y target est | N/A |
- Business Wire
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union
NEW YORK & MAINZ, Germany, June 27, 2024--Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing authorization for the companies’ Omicron JN.1-adapted monovalent COVID-19 vaccine (COMIRNATY® JN.1) for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older. The adaptation is based on the
- Business Wire
Pfizer Declares Third-Quarter 2024 Dividend
NEW YORK, June 26, 2024--Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.42 third-quarter 2024 dividend on the company’s common stock, payable September 3, 2024, to holders of the Common Stock of record at the close of business on July 26, 2024. The third-quarter 2024 cash dividend will be the 343rd consecutive quarterly dividend paid by Pfizer.
- Business Wire
Pfizer Invites Public to View and Listen to Webcast of July 30 Conference Call with Analysts
NEW YORK, June 18, 2024--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:30 a.m. EDT on Tuesday, July 30, 2024. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s Second Quarter 2024 Performance Report, to be issued that morning.
